Rhythm Pharmaceuticals Inc
F:1RV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhythm Pharmaceuticals Inc
F:1RV
|
US |
|
BNP Paribas SA
PAR:BNP
|
FR |
|
W
|
Wilmar International Ltd
F:RTH
|
SG |
|
T
|
Tennant Co
F:TN1
|
US |
|
W
|
Wells Fargo & Co
F:NWT
|
US |
|
J
|
J B Hunt Transport Services Inc
LSE:0J71
|
US |
|
Washington Hotel Corp
TSE:4691
|
JP |
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
Xeriant Inc
OTC:XERI
|
US |
|
Ventas Inc
NYSE:VTR
|
US |
|
Frontier Lithium Inc
XTSX:FL
|
CA |
|
Taihei Dengyo Kaisha Ltd
TSE:1968
|
JP |
|
Wal Mart de Mexico SAB de CV
BMV:WALMEX
|
MX |
|
A
|
Athens Water Supply and Sewerage Company SA
ATHEX:EYDAP
|
GR |
|
B
|
BAE Systems PLC
XMUN:BSP
|
UK |
|
X
|
Xiangcai Co Ltd
SSE:600095
|
CN |
|
G
|
Gala Global Products Ltd
BSE:539228
|
IN |
|
N
|
Nitori Holdings Co Ltd
OTC:NCLTY
|
JP |
|
Starcore International Mines Ltd
TSX:SAM
|
CA |
|
B
|
Beforepay Group Ltd
ASX:B4P
|
AU |
|
I
|
Informa PLC
OTC:IFPJF
|
UK |
|
Olam Group Ltd
F:K25
|
SG |
|
P
|
Pembina Pipeline Corp
F:P5P
|
CA |
|
V
|
Valofe Co Ltd
KOSDAQ:331520
|
KR |
Bankruptcy Probability
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rhythm Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
6.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rhythm Pharmaceuticals Inc has total debt of 93.4m USD. This includes both short-term (0 USD) and long-term (93.4m USD) debt.
You can find a full breakdown on its Balance Sheet.